Paper · 40347374
Exploring Exosome-Based Approaches for Early Diagnosis and Treatment of Neurodegenerative Diseases.
Varshney V and 8 others. Mol Neurobiol, 2025. Cited by 11 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Exploring Exosome-Based Approaches for Early Diagnosis and Treatment of Neurodegenerative Diseases. Papers, record 40347374. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40347374
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Exploring Exosome-Based Approaches for Early Diagnosis and Treatment of Neurodegenerative Diseases.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Exosomes | Major topic |
| Neurodegenerative Diseases | Major topic |
| Humans | |
| Early Diagnosis | |
| Animals | |
| Biomarkers |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References243
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31,422,798 | Concordance between the assessment of Aβ42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid. | Alzheimers Dement | 2019 | https://conductscience.org/library/papers/31422798 | PubMed |
| 2 | 29,669,940 | Generation and testing of clinical-grade exosomes for pancreatic cancer. | JCI Insight | 2018 | https://conductscience.org/library/papers/29669940 | PubMed |
| 3 | 40,027,307 | Global requirements for manufacturing and validation of clinical grade extracellular vesicles. | J Liq Biopsy | 2024 | https://conductscience.org/library/papers/40027307 | PubMed |
| 4 | 30,552,897 | Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients. | Brain Res | 2019 | https://conductscience.org/library/papers/30552897 | PubMed |
| 5 | 35,518,647 | The Role of Exosomes and Exosomal Noncoding RNAs From Different Cell Sources in Spinal Cord Injury. | Front Cell Neurosci | 2022 | https://conductscience.org/library/papers/35518647 | PubMed |
| 6 | 23,562,828 | Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. | J Biotechnol | 2013 | https://conductscience.org/library/papers/23562828 | PubMed |
| 7 | 37,392,659 | A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy. | Biomed Pharmacother | 2023 | https://conductscience.org/library/papers/37392659 | PubMed |
| 8 | 29,357,791 | Neurodegenerative Disorders Treatment: The MicroRNA Role. | Curr Gene Ther | 2017 | https://conductscience.org/library/papers/29357791 | PubMed |
| 9 | 39,595,812 | Exosome Cargo in Neurodegenerative Diseases: Leveraging Their Intercellular Communication Capabilities for Biomarker Discovery and Therapeutic Delivery. | Brain Sci | 2024 | https://conductscience.org/library/papers/39595812 | PubMed |
| 10 | 39,909,378 | Tetraspanin CD9 alters cellular trafficking and endocytosis of tetraspanin CD63, affecting CD63 packaging into small extracellular vesicles. | J Biol Chem | 2025 | https://conductscience.org/library/papers/39909378 | PubMed |
1 to 10 of 243
See all 243 referencesCited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,707,686 | Harnessing Natural Extracellular Vesicles to Combat Age-Related Diseases: From Aging Drivers to Therapeutic Opportunities. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42707686 | PubMed |
| 42,630,266 | Mitochondrial transplantation for delirium superimposed on dementia: from pathogenic mechanisms to clinical translation challenges. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/42630266 | PubMed |
| 42,292,037 | Plant-Derived Exosome-Like Nanoparticles in Neurodegenerative Diseases: From Dual Bioactive-Delivery Roles to Translational Challenges. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42292037 | PubMed |
| 41,810,000 | The Dual Role of Extracellular Vesicles in Aging and Age-Related Diseases: Pathophysiology and Therapeutic Potential. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41810000 | PubMed |
| 41,235,241 | Therapeutic challenges in central nervous system viral infections: advancing mesenchymal stem cell-based strategies for treating neuroinflammation and promoting tissue repair. | Front Immunol | 2025 | https://conductscience.org/library/papers/41235241 | PubMed |
| 40,949,486 | Exosome-Based Therapeutics: A Natural Solution to Overcoming the Blood-Brain Barrier in Neurodegenerative Diseases. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/40949486 | PubMed |
| 40,620,155 | Research progress on mRNA drug delivery strategies in the nervous system. | Nanomedicine (Lond) | 2025 | https://conductscience.org/library/papers/40620155 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| MAPT | 4,137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
| SNCA | 6,622 | PubTator's text mining | https://conductscience.org/library/genes/6622 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40347374
GET https://conductscience.org/api/papers/v1/40347374/references?page=2